Last edition
News about "Drug Substances "
Celltrion to Acquire US Biologics Plant to Counter Potential Pharma Tariffs
Celltrion has been selected as the preferred bidder to acquire a large biologics manufacturing plant in the United States —a strategic move aimed at insulating the company from potential US pharmaceutical tariffs.
Drug Substances | 30/07/2025 | By Dineshwori | 386
Siegfried Opens New Global R&D Center for Drug Substances in Switzerland
Together with the R&D Center in Zofingen, it will offer chemical process R&D and analytical development services for Siegfried’s global Drug Substances network.
Drug Substances | 21/11/2024 | By Aishwarya | 305
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy